Table 2.
Description of children included in Optimising treatment for acute MAlnutrition (OptiMA) protocol, Yako district, Burkina Faso, 2017
(Numbers and percentages; mean values and standard deviations)
| Overall (n 4958) | MUAC <115 mm or oedema (n 824) | MUAC 115–119 mm (n 1070) | MUAC 120–124 mm (n 3064) | |||||
|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | |
| Child socio-demographics characteristics | ||||||||
| Age (months) | ||||||||
| Mean | 14·9 | 12·7 | 14·5 | 15·7 | ||||
| sd | 8·8 | 8·4 | 8·5 | 8·9 | ||||
| Age category | ||||||||
| <24 months | 4077 | 82·2 | 728 | 88·3 | 901 | 84·2 | 2448 | 79·9 |
| ≥24 months | 881 | 17·8 | 96 | 11·7 | 169 | 15·8 | 616 | 20·1 |
| Sex (n 4941) | ||||||||
| Male | 2057 | 41·6 | 326 | 39·8 | 421 | 39·6 | 1310 | 42·8 |
| Female | 2884 | 58·4 | 494 | 60·2 | 641 | 60·4 | 1749 | 57·2 |
| Mode of referral (n 4845) | ||||||||
| Community agent | 1904 | 39·3 | 266 | 33·2 | 406 | 38·7 | 1232 | 41·2 |
| Mothers screening | 628 | 12·9 | 154 | 19·2 | 158 | 15·1 | 316 | 10·5 |
| Outpatient consultation | 2253 | 46·5 | 359 | 44·7 | 476 | 45·3 | 1418 | 47·4 |
| Inpatient consultation | 60 | 1·2 | 23 | 2·9 | 10 | 0·9 | 27 | 0·9 |
| Distance to the health centre (n 4703) | ||||||||
| ≥10 km | 447 | 9·5 | 113 | 14·4 | 122 | 12·0 | 212 | 7·3 |
| <10 km | 4256 | 90·5 | 670 | 85·6 | 894 | 88·0 | 2692 | 92·7 |
| Mother’s characteristics at admission | ||||||||
| Mother’s status (n 4873) | ||||||||
| Alive | 4806 | 98·6 | 786 | 97·4 | 1038 | 98·2 | 2982 | 99·1 |
| Dead | 67 | 1·4 | 21 | 2·6 | 19 | 1·8 | 27 | 0·9 |
| No. of siblings (n 4697) | ||||||||
| 0 | 18 | 0·4 | 5 | 0·7 | 6 | 0·6 | 7 | 0·2 |
| 1–4 | 2711 | 57·7 | 433 | 55·9 | 595 | 59·4 | 1683 | 57·6 |
| 4–12 | 1968 | 41·9 | 336 | 43·4 | 400 | 40·0 | 1232 | 42·2 |
| Breast-feeding (n 4512) | ||||||||
| Yes | 3820 | 84·7 | 652 | 87·7 | 808 | 84·3 | 2360 | 84·0 |
| No | 692 | 15·3 | 91 | 12·3 | 151 | 15·7 | 450 | 16·0 |
| Years of schooling (n 4442) | ||||||||
| No | 3941 | 88·7 | 672 | 90·8 | 855 | 89·6 | 2414 | 87·8 |
| ≥1 year | 501 | 11·3 | 68 | 9·2 | 99 | 10·4 | 334 | 12·1 |
| MUAC training (n 4844) | ||||||||
| Yes | 3733 | 77·1 | 614 | 76·2 | 772 | 74·2 | 2347 | 78·3 |
| No | 1111 | 22·9 | 192 | 23·8 | 268 | 25·8 | 651 | 21·7 |
| Anthropometric characteristics | ||||||||
| MUAC at admission (mm) (n 4922) | ||||||||
| Mean | 118·7 | 109·5 | 116·8 | 121·7 | ||||
| sd | 5·2 | 5·7 | 1·5 | 1·6 | ||||
| WHZ (n 4777) | ||||||||
| Mean | −2·5 | −3·0 | −2·6 | −2·3 | ||||
| sd | 0·9 | 1·1 | 0·9 | 0·9 | ||||
| WHZ categories | ||||||||
| <−3 | 1377 | 28·8 | 423 | 56·3 | 357 | 34·6 | 597 | 19·9 |
| −3 and −2 | 2017 | 42·2 | 239 | 31·8 | 450 | 43·6 | 1328 | 44·3 |
| ≥−2 | 1383 | 29·0 | 89 | 11·9 | 224 | 21·7 | 1070 | 35·7 |
| HAZ (n 4760) | ||||||||
| Mean | −1·7 | −2·2 | −1·8 | −1·6 | ||||
| sd | 1·4 | 1·3 | 1·4 | 1·3 | ||||
| HAZ categories | ||||||||
| <−3 | 848 | 17·8 | 205 | 27·1 | 217 | 21·2 | 426 | 14·3 |
| −3 and −2 | 1150 | 24·2 | 216 | 28·6 | 253 | 24·8 | 681 | 22·8 |
| ≥−2 | 2762 | 58·0 | 335 | 44·3 | 552 | 54·0 | 1875 | 62·9 |
| WAZ (n 4772) | ||||||||
| Mean | −2·8 | −3·4 | −2·9 | −2·5 | ||||
| sd | 0·9 | 0·9 | 0·8 | 0·8 | ||||
| WAZ categories | ||||||||
| <−3 | 1858 | 38·9 | 496 | 68·7 | 494 | 48·1 | 868 | 28·7 |
| −3 and −2 | 2008 | 42·1 | 192 | 26·6 | 406 | 39·5 | 1410 | 46·7 |
| ≥−2 | 906 | 19·0 | 34 | 4·7 | 128 | 12·4 | 744 | 24·6 |
| Malaria data | ||||||||
| Malaria RDT (n 4293) | ||||||||
| Positive | 1103 | 25·7 | 192 | 26·5 | 275 | 29·4 | 636 | 24·1 |
| Negative | 3190 | 74·3 | 532 | 73·5 | 659 | 70·6 | 1999 | 75·9 |
| Received SMC (n 4907) | ||||||||
| Included out of SMC campaign | 3550 | 72·3 | 615 | 75·4 | 785 | 74·3 | 2150 | 70·8 |
| SMC campaign eligible and received | 305 | 6·2 | 41 | 5·0 | 53 | 5·0 | 211 | 6·9 |
| SMC campaign eligible and not received | 1052 | 21·5 | 160 | 19·6 | 218 | 20·6 | 674 | 22·2 |
MUAC, mid upper arm circumference; WHZ, weight-for-height Z-score; HAZ, height-for-age Z-score; WAZ, weight-for-age Z-score; RDT, rapid diagnostic tests; SMC, seasonal malaria chemoprevention during campaign period from July to October 2017.